OS benefit in ARMANI, but is it worth it?

Presented By
Dr Giovanni Randon, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Trial
Phase 3, ARMANI
Conference
ESMO GI 2024
Type
Peer-reviewed article